 Released: Oct 29, 2007
 Expires: Oct 31, 2009
 Type: PDF
Social and clinical advances in the management of human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome (AIDS) continue to occur across the globe. Significant accomplishments include reductions in HIV-associated morbidity and mortality, introduction of less complex medications and dosing regimens, more thorough understandings of the processes...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.40
- Cost: $9.95
-
System Requirements:
|
 Released: Jul 16, 2008
 Expires: Jul 15, 2009
 Type: Audio
Irritable bowel syndrome is a disorder characterized most commonly by cramping, abdominal pain, bloating, constipation, and diarrhea. IBS causes a great deal of discomfort and distress, but it does not permanently harm the intestines and does not lead to a serious disease, such as cancer. Most people can control their symptoms with diet, stress management, and prescribed...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Jul 9, 2008
 Expires: Jul 8, 2009
 Type: Video
Advances in immunosuppressive drug therapy have contributed greatly to the success of solid organ transplantation. Unfortunately, improvements in short-term outcomes as a result of advances in immunosuppressive protocols have yet translated into greater long-term graft survival. Graft survival half-life, a measure of long-term outcome in kidney transplantation, has changed only...
|
- CME Credits/Hours: 1.50
- CNE Credits/Hours: 1.50
- CPE Credits/Hours: 1.50
- Cost: Free
-
System Requirements:
|
 Released: Jul 1, 2008
 Expires: Jul 1, 2009
 Type: PDF
CVD affects approximately 80 million Americans and is responsible for roughly one third of US mortality, with nearly 2400 CVD-associated deaths occurring each day—more than cancer, chronic lower respiratory diseases, accidents, and diabetes mellitus combined 1. CVD is associated with an estimated total annual cost of $400 billion. Among the identified modifiable...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Jul 1, 2008
 Expires: Jun 30, 2009
 Type: PDF
The International Journal of Advances in Rheumatology, a CME/CPE/CNE-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of rheumatoid diseases. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.00
- CNE Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Jul 5, 2006
 Expires: Jun 30, 2009
 Type: Audio
Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better...
|
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Jul 6, 2006
 Expires: Jun 30, 2009
 Type: Audio
Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better...
|
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Jul 4, 2006
 Expires: Jun 30, 2009
 Type: Audio
Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better...
|
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Jun 20, 2008
 Expires: Jun 19, 2009
 Type: PDF
Advances in Pain Management, a CME-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of pain management. It provides rapid access for busy specialists (including pain specialists, anesthesiologists, neurologists, oncologists, general physicians, and primary...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Jun 14, 2007
 Expires: Jun 14, 2009
 Type: Audio
The University of Kentucky College of Pharmacy utilizes pharmacy practitioners as teachers in the experiential education program. These individuals are termed preceptors and usually supervise the educational experience of one or two students at a time in the practice facility where the preceptor works. These experiences take place throughout the curriculum with the greatest...
|
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Jun 11, 2008
 Expires: Jun 10, 2009
 Type: PDF
Rheumatoid arthritis (RA) currently afflicts 1.3 million American adults. A progressive disease of the joints with a recognized autoimmune component, RA causes eventual loss of joint structure and function. The disease is also associated with serious extraarticular and comorbid disease, evidenced by studies identifying a 10-15 year shorter lifespan for patients with RA. RA...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: May 30, 2008
 Expires: May 30, 2009
 Type: Video
Emergency Department (ED) physicians commonly serve as the first healthcare provider contact for patients with a variety of community-acquired cutaneous and respiratory tract infections. As such, they must rapidly make a diagnosis, determine the severity of the process, and institute appropriate empiric therapy. In recent years, drug-resistant bacterial infections have become more...
| Faculty: |
David A. Talan, MD, FACEP, FIDSA;
Peter M.C. DeBlieux, Moderator, MD, FACEP;
Ellen M. Slaven, MD, FACEP, FAAEM;
Kenneth V. Leeper Jr., MD, FCCP
|
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: May 22, 2008
 Expires: May 25, 2009
 Type: PDF
Cytomegalovirus disease (CMV) adversely affects short and long term outcomes following transplantation of allogeneic kidneys, hearts, lungs and livers. Disease prevention strategies, including prophylactic treatment with gancyclovir and related antiviral agents, are routinely implemented in seronegative recipients of organs from seropositive donors (D+/R-). CMV...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: May 15, 2008
 Expires: May 15, 2009
 Type: Audio
Asthma is the leading serious chronic illness of children in the U.S. In 2005, an estimated 6.5 million children under age 18 (almost 1.4 million under age 5) currently had asthma, 3.8 million of which had an asthma attack, and many others have "hidden" or undiagnosed asthma.
In 2005, the highest current prevalence rate was seen in those 5-17 years of age...
|
- CME Credits/Hours: 1.50
- CPE Credits/Hours: 1.50
- Cost: Free
-
System Requirements:
|
 Released: May 12, 2008
 Expires: May 12, 2009
 Type: Audio
Consequences of teen sexual practices amount to almost a million pregnancies, several million sexually transmitted infections and numerous psychological problems. This is directly related to adolescent problems as well as psychosocial and economic factors. Health care providers can make a difference by understanding teen sexuality and learning how to talk to...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Apr 30, 2008
 Expires: Apr 30, 2009
 Type: Audio
Methicillin-resistant Staphylococcus aureus (MRSA) first appeared less than one year after the clinical introduction of methicillin. Despite this early appearance, MRSA did not become a significant and common clinical problem until the 1980s. Since that time, national rates of MRSA past 50%. In addition, a new therapeutic dilemma has emerged; that of community-associated...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Apr 30, 2008
 Expires: Apr 30, 2009
 Type: Audio
In the United States, sepsis is the leading cause of death in non-coronary ICU patients, and the tenth most common cause of death overall according to data from the Centers for Disease Control and Prevention. Sepsis is common and also more dangerous in elderly, immunocompromised, and critically ill patients. It occurs in 1%-2% of all hospitalizations and accounts for as much as 25%...
|
- CME Credits/Hours: 0.75
- Cost: Free
-
System Requirements:
|
 Released: Feb 4, 2008
 Expires: Mar 24, 2009
 Type: Audio
This course is designed to provide the participant with the information needed to perform the complex task of aseptic compounding of sterile products in a pharmacy setting. The major challenge is to ensure that the compounded product has a high level of sterility assurance and that the product administered to the patient is safe and...
|
- CPE Credits/Hours: 1.00
- Cost: $19.95
-
System Requirements:
|
 Released: Mar 1, 2008
 Expires: Mar 1, 2009
 Type: Audio
Inadequate initial coverage of infections in ICU patients is associated with an increase in mortality. Prolonged time to initiation of antimicrobial therapy is also associated with increased mortality. Numerous factors exist which may hinder the most optimal care. Practitioners should be aware of the literature regarding this issue and engage in strategies to increase efficiency...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Mar 2, 2008
 Expires: Mar 1, 2009
 Type: PDF
Each issue of the International Journal of Advances in Rheumatology will present carefully constructed, leading (review) articles, written by practicing rheumatologists and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief,...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Each year an estimated 15 million new STD infections occur in the United States, and nearly 4 million teenagers are infected with an STD. The direct and indirect costs of the major STDs and their complications, including sexually transmitted HIV infection, are conservatively estimated at $17 billion annually. Genital dermatology...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Each year an estimated 15 million new STD infections occur in the United States, and nearly 4 million teenagers are infected with an STD. The direct and indirect costs of the major STDs and their complications, including sexually transmitted HIV infection, are conservatively estimated at $17 billion annually. The estimated annual...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10 infections,...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10 infections,...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10 infections,...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC)...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) remain one of the leading causes of death in the United States (US). As of December 2004, an estimated 944,306 persons have received a diagnosis of AIDS and of these, 529,113 have died. Since 1994, the annual number of HIV cases among blacks and other racial/ethnic minority...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10 infections,...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 28, 2009
 Type: Video
This presentation aims to focus on current strategies to optimize oral antiplatelet agents in the treatment of ACS and PCI. Topics addressed include current limitations with clopidogrel, variability in response to clopidogrel and the clinical outcomes associated with poor response, and strategies to reduce variability. Finally, a comparison of the biologic response of prasugrel and...
|
- CME Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 28, 2009
 Type: Video
This presentation focuses on the results of the TRITON-TIMI 38 trial, which examines the use of the investigational thienopyridine prasugrel compared to clopidogrel in patients with ACS who were undergoing primary PCI. Highlighted data from the trial is presented, including several in-depth analyses investigating sub-populations as it relates to ischemic endpoints as well as...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 28, 2009
 Type: Video
This presentation aims to address the central role of platelets in acute coronary syndromes (ACS) and the use of both oral antiplatelet therapy and interventional therapy as cornerstones for the treatment of ACS. Topics to be discussed include the pharmacology of approved and investigational oral antiplatelet agents, clinical trial data detailing the use of...
|
- CME Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 27, 2009
 Type: Audio
According to data from the National Nosocomial Infections Surveillance (NNIS) System in 2003, the Gram-negative pathogen Pseudomonas aeruginosa was the second most common pathogen causing nosocomial pneumonia in the intensive care unit (ICU), responsible for 18.1% of these infections. Acinetobacter spp also caused hospital-acquired pneumonia (HAP) and accounted for...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 27, 2008
 Expires: Feb 27, 2009
 Type: PDF
Antibiotics: Practice Pearls for the Emergency Department Physician has been developed to provide an overview of the general principles of antibiotic therapy and includes a review the currentclasses of antibiotics available to the emergency department (ED)physician and outlines their place in the clinical armamentarium. Aspects such as indications, dosing schedules, and...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- Credits/Hours:
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- Credits/Hours:
- Cost: Free
-
System Requirements:
|
 Released: Feb 15, 2008
 Expires: Feb 14, 2009
 Type: PDF
Rheumatology Highlights, a CME-accredited educational program, presents a carefully constructed report from a major international conference and is developed to equip readers with practical knowledge of the area under discussion. This newsletter is commissioned to support particular educational themes identified by the Editor-in-Chief, Editorial team and readers. This issue...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 4, 2008
 Expires: Feb 4, 2009
 Type: Video
Kentucky All Schedule Prescription Electronic Reporting (KASPER) is Kentucky’s Prescription Monitoring Program (PMP). KASPER catalogs most of the Schedule II – V controlled substance prescriptions written and dispensed within the state and is used by health care professionals to help address the issue of controlled pharmaceutical substance abuse. We have...
|
- CME Credits/Hours: 1.25
- CPE Credits/Hours: 1.25
- CPE-T Credits/Hours: 1.25
- Cost: Free
-
System Requirements:
|
 Released: Feb 1, 2008
 Expires: Feb 1, 2009
 Type: PDF
The International Journal of Sleep and Wakefulness, a CME-accredited educational program, systematically identifies, evaluates, and places into clinical context the findings of the most important recent studies of disorders of sleep and wakefulness. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that will...
| |